Current trends in the management of ocular symptoms in Adamantiades-Behçet’s disease

References

• HippocratesDilsenNKaktosThird book on epidemiologyCase 7. 1993209
   Google Scholar
• AdamantiadesBA case of recurrent hypopyon iritisMedical Society of Athens1930586593
   Google Scholar
• BehçetHUber rezidivierende aphthose, durch ein Virus verursachte Geschwure am Mud, am Auge und an den GenitalienDerm Wochenschr19373611521157
   Google Scholar
• OhnoSBehçet’s disease in the WorldLehnerTBarnesCGRecent Advances in Behçet’s DiseaseLondonRoyal Society of Medicine Service1986
   Google Scholar
• ChajekTFainaruMBehçet’s disease: Report of 41 cases and a review of the literatureMedicine19755431791961095889
   PubMed Web of Science ®Google Scholar
• O’DuffyJDBehçet’s diseaseKellyWNHarrisEDRuddySSledgeCBTextbook of RheumatologyPhiladelphiaWB Saunders198511741178
   Google Scholar
• MamoJGBaghdassarianABehçet’s disease: A report of 28 casesArch Ophthalmol19647141414066037
   PubMedGoogle Scholar
• ShimizuTClinical and immunological studies on Behçet’s syndromeFolia Ophthalmol Jpn19712210801810
   Google Scholar
• MizukiNOhnoSAndoHA strong association between HLA-B*5101 and Behçet’s disease in Greek patientsTissue Antigen19975015760
   PubMed Web of Science ®Google Scholar
• OhnoSOhguchiMHiroseSClose association of HLA-Bw51 with Behçet’s diseaseArch Ophthalmol19821009145514586956266
   PubMed Web of Science ®Google Scholar
• MishimaSMasudaKIzawaYBehçet’s disease in Japan: Ophthalmologic aspectsTrans Am Ophthalmol Soc197976225279397657
   PubMedGoogle Scholar
• LehnerTBarnesCGCriteria for diagnosis and classification of Behçet’s syndromeLehnerTBarnesCGBehçet’s Syndrome: Clinical and Immunological FeaturesProceedings of a Conference Sponsored by Royal Society of MedicineFebruary 1979LondonAcademic Press197919
   Google Scholar
• NumagaJMatsukiMMochizukiMAn HLA-D region restriction fragment associated with refractory Behçet’s diseaseAm J Ophthalmol198810555285332897165
   PubMed Web of Science ®Google Scholar
• ShikanoSOcular pathology of Behçet’s syndromeMonacelliMNazzaroPInternational Symposium on Behçet’s DiseaseNew YorkKarger, Basel1966111136
   Google Scholar
• LakhanpalSHTaniKLieJTPathologic features of Behçet’s syndrome: A review of Japanese autopsy registry dataHum Pathol19851687907954018777
   PubMed Web of Science ®Google Scholar
• Behçet’s Disease Research Committee of JapanBehçet’s disease: Guide to diagnosis of Behçet’s diseaseJpn J Ophthalmol197418291294
   Google Scholar
• International Study Group for Behçet’s DiseaseCriteria for diagnosis of Behçet’s diseaseLancet19903358697107810801970380
   PubMed Web of Science ®Google Scholar
• PandeIUppalSKailashSBehçet’s disease in India: A clinical, immunological, immunogenetic and outcome studyBr J Rheumatol19953498258307582721
   PubMedGoogle Scholar
• BenamourSZeroualBBennisRMaladie de Behçet. 316 casLa Presse Med1990193214851489
   Google Scholar
• DilsenNKoniceKAralORisk factors for vital organ involvement in Behçet’s diseaseGodeauPWechslerBBehçet’s DiseaseNew YorkElsevier Science1993165169
   Google Scholar
• GharibdoostFDavatchiFShahramFClinical manifestations of Behçet’s disease in Iran: Analysis of 2176 caseseGodeauPWechslerBBehçet’s DiseaseNew YorkElsevier Science1993153158
   Google Scholar
• ImaiYStudies on prognosis and symptoms of Behçet’s disease in long-term observationJpn J Clin Ophthalmol197125665694
   Google Scholar
• BenezraDCohenETreatment and visual prognosis in Behçet’s diseaseBr J Opthalmol19868708589592
   PubMed Web of Science ®Google Scholar
• KaklamaiVGKaklamanisPGTreatment of Behçet’s disease: an updateSemi Arthritis Rheum200130299312
   Web of Science ®Google Scholar
• TokerEKazokogluHAcarNHigh dose intravenous steroid therapy for severe posterior segment uveitis in Behçet’s diseaseBr J Ophthalmol2002586552152311973245
   PubMed Web of Science ®Google Scholar
• EverekliogluCManaging the symptoms of Behçet’s diseaseExpert Opin Pharmacother20045231732814996628
   PubMed Web of Science ®Google Scholar
• Tugal-TutkunIÖnalSAltan YayciogluRUveitis in Behçet’s disease: an analysis of 880 patientsAm J Ophthalmol2004138337338015364218
   PubMed Web of Science ®Google Scholar
• Standarization of Uveitis Nomenclature (SUN) Working GroupStandarization of uveitis nomenclature for reporting clinical data: results of the First International WorkshopAm J Ophthalmol20059140350951616196117
   PubMed Web of Science ®Google Scholar
• YoshikawaKIchiishiAKotabeSPosterior sub-Tenon’s space injection of repository corticosteroids in uveitis patients with cystoid macular edemaNippon Ganka Gakkai Zasshi1993979107010748213367
   PubMedGoogle Scholar
• RothovaAMedical treatment of cystoid macular edemaOcul Immunol Inflamm200210423924612854032
   PubMed Web of Science ®Google Scholar
• FineHBaffiJReedGFAqueous humor and plasma vascular endothelial growth factor in uveitis associated cystoid macular edemaAm J Ophthalmol2001132579479611704050
   PubMed Web of Science ®Google Scholar
• Cordero-ComaMSobrinLOnalSIntravitreal bevacizumab for treatment of uveitic macular edemaOphthalmology200711481574157917363060
   PubMed Web of Science ®Google Scholar
• OkadaAAImmunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literatureOcul Immunol Inflamm200513533535116419419
   PubMed Web of Science ®Google Scholar
• KötterIDürkHSaalJFierlbeckGPleyerUZiehutMTherapy of Behçet’s diseaseGer J Ophthalmol19965292978741153
   PubMedGoogle Scholar
• HamuryudanVOzyazganYHizliNAzathioprine in Behçet’s syndrome: effects on long-term prognosisArthritis Rheum19974047697749125262
   PubMed Web of Science ®Google Scholar
• GreenwoodAJStanfordMRGrahamEMThe role of azathioprine in the management of retinal vasculitisEye199812578378810070509
   PubMed Web of Science ®Google Scholar
• SakaneTTakenoMSuzukiNInabaGBehçet’s diseaseN Engl J Med1999341171284129110528040
   PubMed Web of Science ®Google Scholar
• FosterCSBaeyerJCRaizmanMBTherapeutic response to systemic immunosuppressive chemotherapy agents in patients with Behçet’s syndrome affecting the eyesO’DuffyKEBehçet’s Disease: Basic and Clinical AspectsNew YorkMarcel Dekker1991581588
   Google Scholar
• JabsDARosenbaumJTFosterCSGuidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panelAm J Ophthalmol2000130449251311024423
   PubMed Web of Science ®Google Scholar
• DavatchiFShahramFChamsHHigh dose methotrexate for ocular lesions of Behçet’s disease. Preliminary short-term resultsAdv Exp Med Biol200352857958412918769
   PubMed Web of Science ®Google Scholar
• GhateJVJorizzoJLBehçet’s disease and complex aphthosisJ Am Acad Dermatol1999401118; quiz 19–20.9922007
   PubMed Web of Science ®Google Scholar
• HirohataSSudaHHashimotoTLow-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behçet’s diseaseJ Neurol Sci199815921811859741405
   PubMed Web of Science ®Google Scholar
• WeinblattMEToxicity of low dose methotrexate in rheumatoid arthritisJ Rheumatol Suppl198512Suppl 1235393913775
   PubMedGoogle Scholar
• KremerJMAlarcónGSLightfootRWJrMethotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of RheumatologyArthritis Rheum19943733163288129787
   PubMed Web of Science ®Google Scholar
• WalkerAMFunchDDreyerNADeterminants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritisArthritis Rheum19933633293358452577
   PubMed Web of Science ®Google Scholar
• KempenJHGangaputraSDanielELong-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidenceAm J Ophthalmol20081466802812e1.18579112
   PubMed Web of Science ®Google Scholar
• YuTYuTFMilestones in the treatment of goutAm J Med19745656766854604776
   PubMed Web of Science ®Google Scholar
• EhrenfeldMLevyMBar EliMGallilyREliakimMEffect of colchicine on polymorphonuclear leucocyte chemotaxis in human volunteersBr J Clin Pharmacol19801032973007437248
   PubMed Web of Science ®Google Scholar
• MalawistaSEThe action of colchicine in acute gouty arthritisArthritis Rheum1975186 Suppl8358461201128
   PubMed Web of Science ®Google Scholar
• PesantiELAxlineSGColchicine effects on lysosomal enzyme induction and intracellular degradation in the cultivated macrophageJ Exp Med1975141510301046805204
   PubMed Web of Science ®Google Scholar
• FrayhaRAArthropathy of Behçet’s disease with marked synovial pleocytosis responsive to colchicineArthritis Rheum19822522352367066056
   PubMed Web of Science ®Google Scholar
• AndoKFujinoYHijikataKIzawaYMasudaKEpidemiological features and visual prognosis of Behçet’s diseaseJpn J Ophthalmol199943431231710482479
   PubMed Web of Science ®Google Scholar
• MatsumuraNMizushimaYLeucocyte movement and colchicine treatment in Behçet’s diseaseLancet19752793981378172
   PubMed Web of Science ®Google Scholar
• MizushimaYMatsumuraNMoriMColchicine in Behçet’s diseaseLancet197728046103772942
   PubMed Web of Science ®Google Scholar
• RaynorAAskariADBehçet’s disease and treatment with colchicineJ Am Acad Dermatol1980253964007381068
   PubMed Web of Science ®Google Scholar
• FontesVMachetLHuttenbergerBLoretteGVaillantL[Recurrent aphthous stomatitis: treatment with colchicine. An open trial of 54 cases]Ann Dermatol Venereol2002129121365136912536172
   PubMed Web of Science ®Google Scholar
• MizushimaYBehçet’s diseaseCurr Opin Rheumatol19913132352043450
   PubMedGoogle Scholar
• MasudaKNakajimaAUrayamaANakaeKKogureMInabaGDouble-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet’s diseaseLancet198918647109310962566048
   PubMed Web of Science ®Google Scholar
• EverekliogluCCurrent concepts in the etiology and treatment of Behçet diseaseSurv Ophthalmol200550429735015967189
   PubMed Web of Science ®Google Scholar
• GilmanAG GLRallTWMuradFThe Pharmacological Basis of TherapeuticsNew YorkMacmillan Publishing Company1985709
   Google Scholar
• NewellDRCalvertAHHarrapKRMcElwainTJStudies on the pharmacokinetics of chlorambucil and prednimustine in manBr J Clin Pharmacol19831522532586849759
   PubMed Web of Science ®Google Scholar
• MamoJGAzzamSATreatment of Behçet’s disease with chlorambucilArch Ophthalmol19708444464505492448
   PubMed Web of Science ®Google Scholar
• TesslerHHJenningsTHigh-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet’s diseaseBr J Ophthalmol19907463533572378842
   PubMed Web of Science ®Google Scholar
• MudunBAErgenAIpciogluSUBurumcekEYDurluYArslanMOShort-term chlorambucil for refractory uveitis in Behçet’s diseaseOcul Immunol Inflamm20019421922911935432
   PubMed Web of Science ®Google Scholar
• GoldsteinDAFontanillaFAKaulSSahinOTesslerHHLong-term follow-up of patients treated with short-term high-dose chlorambucil for sight-threatening ocular inflammationOphthalmology2002109237037711825825
   PubMed Web of Science ®Google Scholar
• MiserocchiEBaltatzisSEkongARoqueMFosterCSEfficacy and safety of chlorambucil in intractable noninfectious uveitis: the Massachusetts Eye and Ear Infirmary experienceOphthalmology2002109113714211772593
   PubMed Web of Science ®Google Scholar
• GrupeWEChlorambucil in steroid-dependent nephrotic syndromeJ Pediatr19738245986064121460
   PubMed Web of Science ®Google Scholar
• GuesryPLenoirGBroyerMGonadal effects of chlorambucil given to prepubertal and pubertal boys for nephrotic syndromeJ Pediatr1978922299303621613
   PubMed Web of Science ®Google Scholar
• RichterPCalameraJCMorgenfeldMCKierszenbaumALLavieriJCManciniREEffect of chlorambucil on spermatogenesis in the human with malignant lymphomaCancer1970255102610304910255
   PubMed Web of Science ®Google Scholar
• CallisLNietoJVilaARendeJChlorambucil treatment in minimal lesion nephrotic syndrome: a reappraisal of its gonadal toxicityJ Pediatr19809746536567420231
   PubMed Web of Science ®Google Scholar
• MooreMJClinical pharmacokinetics of cyclophosphamideClin Pharmacokinet19912031942082025981
   PubMed Web of Science ®Google Scholar
• GrochowLBColvinMClinical pharmacokinetics of cyclophosphamideClin Pharmacokinet197945380394389529
   PubMed Web of Science ®Google Scholar
• ShekLPLimDLThalidomide in Behçet’s diseaseBiomed Pharmacother2002561313511908493
   PubMed Web of Science ®Google Scholar
• CalabreseLFleischerABThalidomide: current and potential clinical applicationsAm J Med2000108648749510781782
   PubMed Web of Science ®Google Scholar
• RabinowitzRKatzGRosnerMPri-ChenSSpiererAThe effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurityGraefes Arch Clin Exp Ophthalmol2008246684384818343940
   PubMed Web of Science ®Google Scholar
• LambertKWardJThe use of thalidomide in the management of bleeding from a gastric cancerPalliat Med200923547347519304809
   PubMed Web of Science ®Google Scholar
• AlbertoSFFelixJde DeusJThalidomide for the treatment of severe intestinal bleedingEndoscopy2008409788; author reply 789.18773348
   PubMed Web of Science ®Google Scholar
• BauditzJLochsHAngiogenesis and vascular malformations: antiangiogenic drugs for treatment of gastrointestinal bleedingWorld J Gastroenterol200713455979598418023086
   PubMed Web of Science ®Google Scholar
• DabakVKuriakosePKambojGShurafaMA pilot study of thalidomide in recurrent GI bleeding due to angiodysplasiasDig Dis Sci20085361632163517990111
   PubMed Web of Science ®Google Scholar
• Gardner-MedwinJMSmithNJPowellRJClinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet’s disease: use of neurophysiological studies to detect thalidomide neuropathyAnn Rheum Dis199453128288327864692
   PubMed Web of Science ®Google Scholar
• EisenbudLHorowitzIKayBRecurrent aphthous stomatitis of the Behçet’s type: successful treatment with thalidomideOral Surg Oral Med Oral Pathol19876432892923477744
   PubMedGoogle Scholar
• TrevesRArnaudMJacobP[Speculative ameloriation of arthritis in Behçet disease with thalidomide. A case report]Rev Rhum Mal Osteoartic198451105856533773
   PubMedGoogle Scholar
• HamzaMHTreatment of Behçet’s disease with thalidomideClin Rheumatol1986533653713780143
   PubMed Web of Science ®Google Scholar
• MellinGWKatzensteinMThe saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomaliesN Engl J Med19622671238124413934700
   PubMed Web of Science ®Google Scholar
• OchoniskySVerroustJBastuji-GarinSGherardiRRevuzJThalidomide neuropathy incidence and clinico-electrophysiologic findings in 42 patientsArch Dermatol1994130166698285742
   PubMed Web of Science ®Google Scholar
• De TranQHGuayEChartierSTousignantJTacrolimus in dermatologyJ Cutan Med Surg20015432933511907845
   PubMed Web of Science ®Google Scholar
• DickADExperimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?Br J Ophthalmol199579181887880799
   PubMed Web of Science ®Google Scholar
• MochizukiMImmunotherapy for Behçet’s diseaseInt Rev Immunol199714149669203026
   PubMedGoogle Scholar
• FigueroaMSCiancasEOrteLLong-term follow-up of tacrolimus treatment in immune posterior uveitisEur J Ophthalmol2007171697417294385
   PubMed Web of Science ®Google Scholar
• SloperCMPowellRJDuaHSTacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporineOphthalmology1999106472372810201592
   PubMed Web of Science ®Google Scholar
• HoganACMcAvoyCEDickADLeeRWLong-term efficacy and tolerance of tacrolimus for the treatment of uveitisOphthalmology200711451000100617467532
   PubMed Web of Science ®Google Scholar
• BelardelliFGresserIThe neglected role of type I interferon in the T-cell response: implications for its clinical useImmunol Today19961783693728783497
   PubMedGoogle Scholar
• FeronEJRothovaAvan HagenPMBaarsmaGSSuttorp-SchultenMSInterferon-alpha 2b for refractory ocular Behçet’s diseaseLancet1994343891014287910903
   PubMed Web of Science ®Google Scholar
• Tugal-TutkunIGuney-TefekliEUrganciogluMResults of interferon-alfa therapy in patients with Behçet uveitisGraefes Arch Clin Exp Ophthalmol2006244121692169516673135
   PubMed Web of Science ®Google Scholar
• GueudryJWechslerBTerradaCLong-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet diseaseAm J Ophthalmol20081466837844 e1.19027420
   PubMed Web of Science ®Google Scholar
• FreysdottirJLauSFortuneFGammadelta T cells in Behçet’s disease (BD) and recurrent aphthous stomatitis (RAS)Clin Exp Immunol1999118345145710594567
   PubMed Web of Science ®Google Scholar
• TuranBGallatiHErdiHGurlerAMichelBAVilligerPMSystemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechcet’s disease; soluble TNFR-75 as a biological marker of disease activityJ Rheumatol19972411281329002023
   PubMed Web of Science ®Google Scholar
• HaznedarogluEKaraaslanYBuyukasikYSelectin adhesion molecules in Behçet’s diseaseAnn Rheum Dis2000591616310627429
   PubMed Web of Science ®Google Scholar
• SfikakisPPMarkomichelakisNAlpsoyEAnti-TNF therapy in the management of Behçet’s disease – review and basis for recommendationsRheumatology (Oxford)200746573674117403712
   PubMed Web of Science ®Google Scholar
• GoossensPHVerburgRJBreedveldFCRemission of Behçet’s syndrome with tumour necrosis factor alpha blocking therapyAnn Rheum Dis200160663711350856
   PubMed Web of Science ®Google Scholar
• SfikakisPPBehçet’s disease: a new target for anti-tumour necrosis factor treatmentAnn Rheum Dis200261Suppl 2ii51ii5312379622
   PubMed Web of Science ®Google Scholar
• SfikakisPPTheodossiadisPGKatsiariCGKaklamanisPMarkomichelakisNNEffect of infliximab on sight-threatening panuveitis in Behçet’s diseaseLancet2001358927829529611498218
   PubMed Web of Science ®Google Scholar
• SfikakisPPKaklamanisPHElezoglouAInfliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet diseaseAnn Intern Med2004140540440614996689
   PubMed Web of Science ®Google Scholar
• NiccoliLNanniniCBenucciMLong-term efficacy of infliximab in refractory posterior uveitis of Behçet’s disease: a 24-month follow-up studyRheumatology (Oxford)20074671161116417478466
   PubMed Web of Science ®Google Scholar
• TognonSGrazianiGMarcolongoRAnti-TNF-alpha therapy in seven patients with Behçet’s uveitis: advantages and controversial aspectsAnn N Y Acad Sci2007111047448417911463
   PubMed Web of Science ®Google Scholar
• MainiRNTaylorPCAnti-cytokine therapy for rheumatoid arthritisAnn Rev Med20005120722910774461
   PubMed Web of Science ®Google Scholar
• Thomas-GolbanovCSridharanSNovel therapies in vasculitisExp Opin Invest Drug20011012791289
   PubMed Web of Science ®Google Scholar
• MelikogluMÖzyazganYFreskoIThe response of treatment resistant uveitis in Behçet’s syndrome (BS) to a TNF-α blocker, etanercept: an open studyArthritis Rheum200246181
   Google Scholar
• EvansCAJellisJHughesSPTumor necrosis factor-α, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuverculous osteomyelitisJ Infect Dis1998177158215879607836
   PubMed Web of Science ®Google Scholar
• YücelAEKart-KöseogluHAkovaYAFailure of infliximab treatment and occurrence of erythema nodosum during therpy in two patients with Behçet’s diseaseRheumatology20044339439614963212
   PubMed Web of Science ®Google Scholar
• TognonSGrazianiGMarcolongoRAnti-TNF-alpha therapy in seven patients with Behçet’s uveitis: advantages and controversial aspectsAnn N Y Acad Sci2007111047448417911463
   PubMed Web of Science ®Google Scholar
• YasuiKOhtaKKobayashiMAizawaTKomiyamaASuccessful treatment of Behçet disease with pentoxifyllineAnn Intern Med1996124108918938610918
   PubMed Web of Science ®Google Scholar
• Accardo-PalumboAFerranteACicciaFPentoxifylline inhibits Vgamma9/Vdelta2 T lymphocyte activation of patients with active Behçets disease in vitroInt J Immunopathol Pharmacol200720360160617880773
   PubMed Web of Science ®Google Scholar
• NambaKSonodaKHKitameiHGranulocytapheresis in patients with refractory ocular Behçet’s diseaseJ Clin Apher200621212112816395727
   PubMed Web of Science ®Google Scholar
• RojasBZafirakisPFosterCSCataract surgery in patients with uveitisCurr Opin Ophthalmol1997861210168276
   PubMedGoogle Scholar
• SulluYOgeIErkanDThe results of cataract extraction and intraocular lens implantation in patients with Behçet’s diseaseActa Ophthalmol Scand200078668068311167232
   PubMedGoogle Scholar
• BerkerNSoykanEElginUOzkanSSPhacoemulsification cataract extraction and intraocular lens implantation in patients with Behçet’s diseaseOphthalmic Surg Lasers Imaging200435321521815185789
   PubMedGoogle Scholar
• KadayifcilarSGedikSEldemBIrkecMCataract surgery in patients with Behçet’s diseaseJ Cataract Refract Surg200228231632011821216
   PubMed Web of Science ®Google Scholar
• Da MataABurkSENetlandPABaltatzisSChristenWFosterCSManagement of uveitic glaucoma with Ahmed glaucoma valve implantationOphthalmology1999106112168217210571354
   PubMed Web of Science ®Google Scholar
• HillRANguyenQHBaerveldtGTrabeculectomy and Molteno implantation for glaucomas associated with uveitisOphthalmology199310069039088510904
   PubMed Web of Science ®Google Scholar
• JampelHDJabsDAQuigleyHATrabeculectomy with 5- fluorouracil for adult inflammatory glaucomaAm J Ophthalmol199010921681732301528
   PubMed Web of Science ®Google Scholar
• PatitsasCJRockwoodEJMeislerDMLowderCYGlaucoma filtering surgery with postoperative 5-fluorouracil in patients with intra-ocular inflammatory diseaseOphthalmology19929945945991302458
   PubMed Web of Science ®Google Scholar
• PrataJAJrNevesRAMincklerDSMermoudAHeuerDKTrabeculectomy with mitomycin C in glaucoma associated with uveitisOphthalmic Surg19942596166607831006
   PubMedGoogle Scholar
• TowlerHMMcCluskeyPShaerPLightmanSLong-term follow-up of trabeculectomy with intraoperative 5-fluorouracil for uveitis-related glaucomaOphthalmology2000107101822182811013180
   PubMed Web of Science ®Google Scholar
• CeballosEMBeckADLynnMJTrabeculectomy with antiproliferative agents in uveitic glaucomaJ Glaucoma200211318919612140394
   PubMed Web of Science ®Google Scholar
• YalvacISSungurGTurhanEEksiogluUDumanSTrabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet’s diseaseJ Glaucoma200413645045315534468
   PubMed Web of Science ®Google Scholar
• OzdemirOErkamNBakkalogluAResults of pars plana vitrectomy in Behçet’s diseaseAnn Ophthalmol198820135383345059
   PubMedGoogle Scholar
• SoyluMDemircanNPelitAPars plana vitrectomy in ocular Behçet’s diseaseInt Ophthalmol200124421922312678399
   PubMedGoogle Scholar
• OzerturkYBardakYDurmusMVitreoretinal surgery in Behçet’s disease with severe ocular complicationsActa Ophthalmol Scand200179219219611284762
   PubMedGoogle Scholar
• SulluYAlotaibyHBedenUErkanDPars plana vitrectomy for ocular complications of Behçet’s diseaseOphthalmic Surg Lasers Imaging200536429229716156145
   PubMedGoogle Scholar
• KrauseLAltenburgABechrakisNEWillerdingGZouboulisCCFoersterMHIntraocular surgery under systemic interferon-alpha therapy in ocular Adamantiades-Behçet‘s diseaseGraefes Arch Clin Exp Ophthalmol2007245111617162117431663
   PubMed Web of Science ®Google Scholar
• AtmacaLSExperience with photocoagulation in Behçet’s diseaseOphthalmic Surg1990215715762234807
   PubMedGoogle Scholar
• Tugal-TutkunIOnalSAltan-YayciogluRKirNUrganciogluMNeovascularization of the optic disc in Behçet’s diseaseJpn J Ophthalmol200650325626516767382
   PubMed Web of Science ®Google Scholar
• NewmanNMHoytWFSpencerWHMacula-sparing monocular blackouts: Clinical and pathologic investigation of intermittent choroidal vascular insufficiency in a case of periarteritis nodosaArch Ophthalmol19749153673704150748
   PubMedGoogle Scholar
• GoldDHOcular manifestations of connective tissue (collagen) diseasesTasmanWJaegerAEDuane’s Clinical OphthalmologyPhiladelphiaJ.B. Lippincott198951719
   Google Scholar